Further studies of SRF in a variety of xenograft tumor models (for example in KB-3-1- and KB-V1-xenografted mice) might provide insightful information into chemotherapeutic potential of SRF as a novel microtubule-targeting agent. This evidence concerns the gene SRF and neoplasm.